Teleflex Incorporated (NYSE:TFX) Stock Holdings Lifted by Oak Thistle LLC

Oak Thistle LLC raised its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 243.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 10,695 shares of the medical technology company's stock after acquiring an additional 7,585 shares during the period. Teleflex accounts for about 0.6% of Oak Thistle LLC's holdings, making the stock its 29th biggest position. Oak Thistle LLC's holdings in Teleflex were worth $1,903,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in TFX. Janus Henderson Group PLC increased its stake in Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the last quarter. State Street Corp grew its holdings in Teleflex by 1.0% in the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock valued at $508,757,000 after buying an additional 21,291 shares during the period. Geode Capital Management LLC grew its holdings in Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after buying an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock valued at $105,749,000 after acquiring an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its holdings in shares of Teleflex by 31.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company's stock worth $100,768,000 after acquiring an additional 96,958 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on TFX. Truist Financial decreased their price target on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a report on Wednesday, December 18th. Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research report on Friday, November 1st. Royal Bank of Canada reduced their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Monday, December 16th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Teleflex currently has a consensus rating of "Moderate Buy" and a consensus target price of $252.50.

Teleflex Stock Down 1.6 %

TFX traded down $2.84 during trading hours on Wednesday, reaching $176.33. 600,491 shares of the stock traded hands, compared to its average volume of 484,767. Teleflex Incorporated has a fifty-two week low of $171.69 and a fifty-two week high of $256.85. The company has a market cap of $8.19 billion, a price-to-earnings ratio of 35.06, a PEG ratio of 1.84 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm's fifty day simple moving average is $185.27 and its two-hundred day simple moving average is $216.16.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same period last year, the firm earned $3.64 earnings per share. The company's revenue was up 2.4% on a year-over-year basis. As a group, analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date was Friday, November 15th. Teleflex's payout ratio is currently 27.04%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.